Dyfyniad APA

Sharon, Y., & Chu, D. S. (2020). Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis. Am J Ophthalmol Case Rep.

Dyfyniad Arddull Chicago

Sharon, Yael, and David S. Chu. "Certolizumab Pegol – Tumor Necrosis Factor Inhibitor for Refractory Uveitis." Am J Ophthalmol Case Rep 2020.

Dyfyniad MLA

Sharon, Yael, and David S. Chu. "Certolizumab Pegol – Tumor Necrosis Factor Inhibitor for Refractory Uveitis." Am J Ophthalmol Case Rep 2020.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.